Press Releases

This strategic milestone marks a significant step forward in Roquette's ambition to become a leader in support of the global pharma markets.

Beauté by Roquette^® ST 305 has an advanced patent-pending porous structure with unique compaction properties and sensory benefits, making it an ideal alternative to mineral and synthetic powders.

Driven by its Pharmaceutical Activities, Roquette's 2024 Results Demonstrate the Resilience of its Integrated Business Model.

This brand-new center entirely devoted to cosmetics is a testament of Roquette’s commitment to innovation, collaboration, and excellence in plant-based ingredients for cosmetics.

Roquette launches a new coatings platform, combining cutting-edge performance with eco-consciousness, designed to meet the growing demand in prescription pharmaceutical, nutraceutical, and OTC markets. 

This successfull completion aims at supporting its transformative acquisition of IFF Pharma solutions. The bond offering was met with enthusiastic response from high-quality investors.

The Notes offering was very well received by the market and largely oversubscribed. This outcome reflects strong investor confidence in the company’s growth strategy and solid credit profile.

The Roquette Foundation for Health has awarded its 3rd Research Prize to scientist Delphine Payros and her team, for their work on the toxicity of multiple dietary exposures involving mycotoxins in digestive pathophysiology. 

Roquette iannounces the expansion of its texturizing solutions range with the addition of four new tapioca-based cook-up starches.

The Roquette Foundation for Health and the Decathlon Foundation present the winners of their call for projects "Sport and Nutrition for Good Health!"

Roquette and Bonumoseare pleased to announce the signing of a Cooperation Agreement that aims to advance the development of tagatose, a natural-origin sweetener with clinically proven health benefits.

Roquette presents its life+nature program, aimed at renewing and strengthening its sustainability approach, and defining some ambitious targets for 2030.

Roquette Breaks New Ground in Plant-Based Ingredient Innovation with NUTRALYS® Fava S900M – Its First Fava Bean Protein Isolate.

Roquette launches of its new LYCAGEL® Flex hydroxypropyl pea starch premix for nutraceutical and pharmaceutical softgel capsules.

Roquette has appointed Barentz International as the sole distributor for their cosmetics ingredients in USA, effective as of May 1, 2024.